Initial phase study marks the clinical evaluation of the Abreu BTT 700 TMS and its thermofebrile protocol, laying the foundation for future efficacy trials in the treatment of ALS and other neurodegenerative disorders Dr. M. Marc Abreu, BTT Founder and Chief Medical Officer Dr. Abreu…

Read More

Editor' Pick

Canada News

Lifestyle

Tech & Innovation

Latest News